NDA 50803, held by Chartwell Rx. Clindamycin Phosphate; Tretinoin.
As of Nov 13, 2026, NDA 50803 (Veltin), held by Chartwell Rx, was first approved by FDA on Jul 16, 2010, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 16, 2010 | Original applicationNew formulation or manufacturer · Standard review | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Veltin1.2%;0.025% · gel;topical | Clindamycin Phosphate; Tretinoin | RxReference drug |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
